Foxglove (Digitalis purpurea) is one of the most medically significant plants in history, and also one of the most lethal if misused. Its leaves contain cardiac glycosides that gave rise to digoxin and digitoxin, drugs prescribed for heart failure and abnormal heart rhythms for over two centuries. But the gap between a therapeutic dose and a fatal one is razor-thin, making foxglove a plant that deserves respect from gardeners, foragers, and anyone curious about herbal medicine alike.
From Folk Remedy to Modern Drug
The medicinal story of foxglove traces back to 1785, when the English physician William Withering published a landmark report on treating 163 patients suffering from “dropsy,” or fluid retention, with preparations made from foxglove leaves. Withering catalogued each patient’s response and identified that the people who benefited most were those whose fluid buildup was caused by heart failure rather than other conditions.1PubMed. Individual response to treatment: from Withering to contemporary medicine That insight laid the groundwork for cardiac glycoside therapy, which eventually led to the purification of digoxin in the twentieth century. Digoxin became one of the most widely prescribed heart drugs in the world, and its origins in a common garden flower remain one of pharmacology’s most striking examples of nature yielding a powerful medicine.
How Foxglove Compounds Affect the Heart
The active chemicals in foxglove belong to a class called cardiac glycosides. When these compounds enter the body, they block a specific pump on heart muscle cells that normally moves sodium out. With sodium building up inside the cell, a separate exchange mechanism brings more calcium in. That extra calcium makes each heartbeat stronger, which is why doctors describe the effect as “positive inotropic,” meaning it increases the force of the heart’s contractions.2PubMed. Sodium pump inhibition, enhanced calcium influx via sodium-calcium exchange, and positive inotropic response in cultured heart cells
Beyond strengthening contractions, digoxin also slows electrical conduction through a critical relay point in the heart called the atrioventricular node. This property is what makes it useful in atrial fibrillation, a condition where the upper chambers of the heart fire erratically and too quickly. Digoxin lengthens the refractory period of that node, essentially filtering out some of the chaotic signals and preventing the lower chambers from beating dangerously fast.3Research Reports in Clinical Cardiology. Role of digoxin in controlling the ventricular rate during atrial fibrillation: a systematic review and a rethinking
Proven Clinical Uses
The best-studied use of digoxin is in heart failure with reduced ejection fraction, meaning the heart’s pumping chamber does not squeeze out enough blood with each beat. The largest trial on this, known as the DIG trial, enrolled thousands of patients and found that digoxin did not reduce overall mortality compared with placebo but significantly cut hospitalizations. Roughly 27% of patients on digoxin were hospitalized for worsening heart failure, compared with about 35% in the placebo group.4PubMed. The effect of digoxin on mortality and morbidity in patients with heart failure For patients and health systems, fewer hospital stays is a meaningful benefit even when the drug does not extend life on its own.
A deeper analysis of that same trial later revealed that the dose matters enormously. Patients whose blood levels of digoxin fell in a low range, between 0.5 and 0.9 nanograms per milliliter, actually did see a reduction in mortality of roughly 23% compared with placebo, along with substantially fewer hospitalizations for heart failure. At higher blood concentrations, the mortality benefit disappeared, though hospitalizations still dropped.5PubMed Central. Digoxin and Reduction in Mortality and Hospitalization in Heart Failure: A Comprehensive Post-Hoc Analysis of the DIG Trial This finding reshaped how doctors think about the drug: low doses appear to hit a sweet spot where the benefits outweigh the risks, while pushing the blood level higher buys you diminishing returns at increasing danger.
The other established use is controlling heart rate in atrial fibrillation. Digoxin is not the first-line choice for most patients with this condition, but it fills a specific niche for people who cannot tolerate other rate-control drugs or who also have heart failure. In that setting, the combination of a stronger heartbeat and a slower ventricular rate can make a noticeable difference in how a patient feels day to day.
Why Digoxin’s Role Has Shrunk
Despite its long history, digoxin has been steadily pushed to the margins of cardiology. The 2021 European Society of Cardiology guidelines and the 2022 American College of Cardiology guidelines both assigned it relatively low recommendation levels: a weak endorsement for heart failure patients who remain symptomatic after other therapies, and a moderate endorsement for rate control in atrial fibrillation only when preferred drugs like beta-blockers are unsuitable.6PubMed Central. The comeback of digitalis (digitoxin): the DIGIT-HF trial Newer drug classes, including several that actually do reduce mortality in heart failure, have largely taken over. Digoxin now occupies a role closer to a backup option than a frontline treatment.7PubMed Central. Effects of Digoxin in Heart Failure With Reduced Ejection Fraction
Part of the reason for this decline is practical: digoxin is simply hard to use safely. Its therapeutic window, the range of blood concentrations where the drug helps rather than harms, sits between 0.5 and 2.0 nanograms per milliliter.8PubMed. Digoxin detection for therapeutic drug monitoring using target-triggered aptamer hairpin switch and nicking enzyme-assisted signal amplification As the post-hoc DIG analysis showed, even the upper half of that range loses the mortality benefit. Patients on digoxin need periodic blood draws to make sure they remain in the safe zone, and factors like kidney function, electrolyte levels, and other medications can shift that zone unpredictably.
Dangerous Drug Interactions
One of the more treacherous aspects of digoxin therapy is how many common medications can push its blood level into toxic territory or amplify its effects on the heart. The combination of digoxin with amiodarone, another antiarrhythmic drug frequently prescribed for atrial fibrillation, has drawn particular concern. A large study of patients with atrial fibrillation found that those taking both drugs together had an all-cause mortality rate of about 37%, compared with roughly 27% for those on digoxin alone.9PubMed Central. Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation Amiodarone raises digoxin blood levels by interfering with its clearance, so any patient on both drugs needs especially close monitoring.
Beyond amiodarone, many other medications and conditions can tip the balance. Diuretics commonly used in heart failure can deplete potassium, and low potassium sensitizes heart cells to digoxin’s effects, increasing the risk of dangerous rhythms even when digoxin blood levels appear normal. Kidney impairment slows digoxin clearance and lets it accumulate. Older adults are at higher risk for all of these interactions simultaneously, which is one reason many cardiologists have become cautious about prescribing the drug at all.
What Foxglove Toxicity Looks Like
Digoxin toxicity, whether from a prescribed overdose or from eating the plant directly, tends to announce itself with a distinctive set of symptoms. Nausea, vomiting, and diarrhea often come first. Cardiac problems follow, including dangerously slow heart rates, irregular rhythms, and in severe cases, life-threatening arrhythmias. One case report described a 38-year-old man who arrived at a hospital with vomiting, diarrhea, elevated potassium, and sinus bradycardia after ingesting foxglove.10PubMed. Unusual digoxin toxicity with myocardial injury
The visual disturbances are perhaps the most famous hallmark of foxglove poisoning. Xanthopsia, or seeing the world with a yellow tint, is the classic symptom. Patients have also reported green-tinted vision, sensitivity to light, visual hallucinations, and blurred sight. These visual changes typically resolve within days to weeks after the drug is stopped.11PubMed Central. Xanthopsia Due to Digoxin Toxicity as a Cause of Traffic Accidents: A Case Report Art historians have speculated that Vincent van Gogh’s yellow-dominated paintings may reflect xanthopsia from digitalis treatment he received from his physician, though that theory remains debated. What is not debated is that the visual symptoms can impair everyday tasks: the same case report linked xanthopsia to a traffic accident where the patient could not perceive colors or distances correctly.
How Poisoning Is Treated
The development of an antidote for digoxin poisoning is one of the success stories of modern toxicology. Digoxin-specific antibody fragments, produced in sheep, bind to digoxin molecules in the bloodstream and neutralize them. In a landmark multicenter study of 150 patients with life-threatening digitalis toxicity, 80% had complete resolution of all signs and symptoms after receiving these antibody fragments, another 10% improved, and the median time to initial response was just 19 minutes.12PubMed. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study
Across larger case series combining acute and chronic poisonings, response rates to digoxin-specific antibody fragments ranged from about 50% to 90%, with reversal of toxicity typically occurring within 30 to 45 minutes. Free digoxin in the blood drops to near zero within minutes of administration.13PubMed. Digoxin-specific antibody fragments in the treatment of digoxin toxicity The antidote is effective and relatively fast, but it is expensive and not universally available in every hospital, which makes prevention the more important priority.
The Foraging Trap
Foxglove poisoning from wild plant ingestion is rarer than prescribed-drug toxicity, but the cases that do occur tend to be alarming. The most common scenario involves mistaking foxglove leaves for comfrey (Symphytum officinale), a plant used in herbal teas and poultices. Before flowering, the two plants look strikingly similar, with broad, fuzzy, tongue-shaped leaves growing in basal rosettes close to the ground.
In one documented outbreak, nine people drank herbal tea made from what they believed was comfrey but turned out to be foxglove. All developed nausea, vomiting, diarrhea, and dizziness. Three of the patients who also had elevated potassium levels went on to develop significant heart toxicity requiring temporary cardiac pacing. Blood tests showed digoxin levels ranging from 4.4 to a staggering 139.5 nanograms per milliliter, far above the therapeutic ceiling of 2.0.14Journal of the Chinese Medical Association. An Outbreak of Foxglove Leaf Poisoning All nine patients ultimately recovered, but the case demonstrates how badly things can go wrong from a single misidentified herb.
Not all patients are so fortunate. A separate case report described a fatal outcome when a patient ingested foxglove after mistaking it for comfrey and developed refractory ventricular arrhythmias that could not be corrected.15PubMed. Fatal cardiac glycoside poisoning due to mistaking foxglove for comfrey The message for foragers and anyone who works with fresh herbs is straightforward: never consume any part of foxglove, and never harvest wild plants you cannot identify with absolute certainty while they are in bloom and distinguishable. The toxins are present in all parts of the plant, including the flowers, stems, seeds, and roots, and no amount of drying or brewing eliminates them.
Animals and Foxglove
Foxglove poisoning is not limited to humans. Livestock that graze on pastures where foxglove grows can accidentally ingest the plant, and cases have been documented in cattle and other domestic animals. Horses, cattle, sheep, and goats are all susceptible, and even relatively small quantities of the plant can cause the same cardiac disruptions seen in people. Pet owners with foxglove in their gardens should be aware that dogs and cats who chew on the leaves or flowers are equally at risk. Symptoms in animals mirror those in humans: gastrointestinal upset, cardiac arrhythmias, and potentially death.
Interestingly, some insects have evolved the ability to tolerate or even exploit cardiac glycosides. Certain species of flies and caterpillars that feed on digitalis plants have developed specialized transport proteins that protect their cells from the toxic effects. Research on fruit fly models has shown that knocking out these protective proteins makes the flies die faster and suffer worse neurological effects when exposed to cardenolides at the concentrations found naturally in plants.16PubMed Central. Multidrug transporters and organic anion transporting polypeptides protect insects against the toxic effects of cardenolides The most famous example of this strategy in the wild is the monarch butterfly, which sequesters cardenolides from milkweed (a different plant family with related toxins) and becomes unpalatable to predators. Foxglove’s cardiac glycosides likely evolved as a chemical defense against herbivory, and the ongoing arms race between plants and the insects that feed on them continues to interest evolutionary biologists.
Emerging Research Beyond Heart Disease
One of the more surprising developments in foxglove-derived chemistry is the growing interest in cardiac glycosides as potential cancer fighters. Laboratory studies have found that these compounds can inhibit cancer cell growth at very low concentrations, and high-throughput drug screens have repeatedly flagged cardiac glycosides as potent blockers of tumor cell proliferation. In rodent models, cardiac glycosides have slowed tumor growth, lending some credibility to the idea that they might one day have a role in oncology.17PubMed Central. Evaluating the cancer therapeutic potential of cardiac glycosides
More recent work has expanded the list of potential applications even further. Cardiac glycosides appear to trigger multiple forms of cancer cell death, interfere with tumor blood vessel formation, and block some of the processes tumors use to spread. Researchers have also documented antiviral activity against a range of viruses, including influenza, HIV, herpes simplex, and SARS-CoV-2, by disrupting viral entry and replication steps.18PubMed Central. Cardiac Glycosides: From Natural Defense Molecules to Emerging Therapeutic Agents None of this work has reached the stage of approved treatments in humans, and the narrow margin between helpful and harmful doses remains a fundamental hurdle. But the breadth of biological activity packed into these molecules, originally just the plant’s insect repellent, continues to attract research interest.
Foxglove in the Garden and the Wild
Despite its fearsome pharmacology, foxglove is one of the most popular ornamental biennials in temperate gardens. It thrives in partial shade, tolerates poor soil, and self-seeds freely once established. The tall spires of tubular flowers, which come in purple, pink, white, and yellow depending on the species and cultivar, are a magnet for bumblebees. Observational studies of wild foxglove populations in the United Kingdom found that the garden bumblebee (Bombus hortorum) was by far the dominant pollinator, accounting for 82 to 92% of all insect visits. That particular bumblebee species, with its unusually long tongue, shows a strong preference for the deep tubular flowers of foxglove over other available blooms.19Journal of Pollination Ecology. The bumblebee Bombus hortorum is the main pollinating visitor to Digitalis purpurea (Common Foxglove) in a U.K. population
Gardeners who grow foxglove around children or pets should take basic precautions. Wearing gloves when handling the plants is wise, since the cardiac glycosides can be absorbed through skin in theory, though serious poisoning from casual contact is extremely rare. The more realistic risk is a curious toddler or puppy chewing on a leaf or flower. Placing foxglove toward the back of borders, out of easy reach, and teaching children never to put any garden plant in their mouth are sensible steps. Composting foxglove material is generally fine, as the glycosides break down, but fresh trimmings should not be left where animals might browse on them.
For anyone drawn to foraging or wildcrafting, the lesson of foxglove is a broader one about plant identification. Several edible and medicinal plants share superficial resemblances with toxic species when they are not flowering, and comfrey-foxglove confusion is just the most documented example. Relying on a single identifying feature, like leaf shape, is never sufficient. Confirming flower structure, growth habit, stem characteristics, and habitat before consuming any wild plant is the minimum standard that separates safe foraging from a hospital visit.